Docmode Health Technologies IPO Final Subscribed 215.24 times

About the Docmode Health Technologies IPO

The stock of Docmode Health Technologies IPO has a face value of ₹10 per share and it is a fixed price issue. The price for the fixed price issue has been set at ₹79 per share. The IPO of Docmode Health Technologies Ltd has only a fresh issue component and no offer for sale (OFS) portion. While the fresh issue portion is EPS dilutive and equity dilutive, the OFS is just a transfer of ownership and  hence it is not EPS or equity dilutive. As part of the fresh issue portion of the IPO, Docmode Health Technologies IPO will issue a total of 8,49,600 shares (8.496 lakh shares), which at the fixed IPO price of ₹79 per share aggregates to fresh fund raising of ₹6.71 crore. Since there is no offer for sale (OFS) portion, the fresh issue size will also double up as the overall IPO size. Therefore, the overall IPO size will also comprise of the issue of 8,49,600 shares (8.496 lakh shares) which at the fixed IPO price of ₹79 per share will aggregate to overall IPO size of ₹6.71 crore.

Like every SME IPO, this issue also has a market making portion with a market maker inventory allocation of 43,200 shares. Rikhav Securities Ltd will be the market maker to the issue. The market maker provides two-way quotes to ensure liquidity on the counter and low basis costs, post listing. The company has been promoted by Paulson Paul Thazhathedath and Hans Albert Lewis. Post the IPO, the promoter stake will get diluted from 65.02% to 47.44%. The fresh issue funds will be used by the company for purchase of IT infrastructure and operating systems, and for meeting the incremental working capital needs of the company. Fedex Securities Private Ltd will be the lead manager to the issue, and Bigshare Services Private Ltd will be the registrar to the issue. The market maker for the issue is Rikhav Securities Ltd.

Final subscription status of Docmode Health Technologies IPO

Here is subscription status of Docmode Health Technologies IPO at close on 30th January 2024.

As can be seen from the above table, the overall IPO of Docmode Health Technologies Ltd got subscribed an impressive 215.24 times. The retail portion led the stakes with 230.38 times subscription, followed by the HNI / NII portion at 194.90 times subscription. There was no dedicated QIB allocation in this IPO. That is a very strong and smart response to an SME IPO, especially if you consider the median subscriptions that similar other SME IPOs have got in the past. The subscription has shown strong traction for the IPO across both the categories of investors; retail and HNI / NII investors.

Allocation quota for various categories

The issue was open for retail investors and the HNI / NII investors. There was a broad quota designed for each of the segments viz. the retail, and the HNI / NII segments. A total of 43,200 shares were allocated as market maker portion to Rikhav Securities Ltd, which will act as market maker inventory to provide bid-ask liquidity on the counter post listing. Market maker action not only improves liquidity in the counter but also reduces the basis risk. The table below captures the allocation reservation done for each of the categories out of the total number of shares offered in the IPO.

In the above IPO of Docmode Health Technologies Ltd, there is no QIB allocation in the IPO. The anchor allocation to the anchor investors is normally done out of this QIB allocation and hence the company has not done any anchor allocation in the IPO. Normally, the anchor is done to institutional investors, which gives confidence and assurance to the retail shareholders about the institutional interest in the stock The anchor allocation is normally adjusted and deducted from the QIB quota and only the net number of shares is available for public issue under the QIB portion.

However, in this case, there is neither any QIB quota, nor any anchor allocation to investors ahead of the IPO. Normally, the anchor portion bidding is done on the day before the IPO opens and such anchor investments are subjected to lock in at two levels. Half the anchor allocation is locked in for 30 days while the balance anchor allocation shares are locked in for a period of 90 days. The allocation of market maker inventory of 5.08% is outside the anchor portion. The market making portion is more towards ensuring liquidity post listing and ensuring low basis spreads on the stock.

How subscription built up for the Docmode Health Technologies IPO

The oversubscription of the IPO was dominated by the retail investors followed by the HNI / NII category in that order. The table below captures the day-wise progression of the subscription status of Docmode Health Technologies Ltd. The IPO was kept open for 3 working days.

Here are the key takeaways from the subscription numbers on a day-wise basis for Docmode Health Technologies Ltd.

• The retail portion got the best subscription in the Docmode Health Technologies Ltd IPO at 230.38 times and it got 4.95 times subscribed on the first day of the IPO itself.
   
• The HNI / NII portion was behind the retail portion in terms of subscription at 194.90 terms overall and it got 0.60 times subscribed at the end of the first day.
   
• While the retail portion got fully subscribed on the first day of the IPO itself, the HNI / NII portion only got fully subscribed on the second day of the IPO. However, the overall IPO got fully subscribed on first day  itself. The overall IPO which saw subscription of 215.24 times got fully subscribed at 16.88 times at the close of the first day itself.
   
• The retail, and HNI / NII portion saw the best traction on the last day of the IPO. The HNI / NII portion saw the total subscription ratio moving from 8.27X to 194.90X on the last day of the IPO. Even the retail portion saw the total subscription ratio move from 42.04X to 230.38X on the last day of the IPO.
   
• The last day traction story was true regarding the overall IPO subscription ratio also. The subscription ratio overall moved from 25.19X to 215.24X on the last day of the IPO.

Next steps in the IPO process

With the IPO closed for subscription at the end of January 30th, 2024, the next piece of action shifts to the finalization of the basis of allotment and later to the listing of the IPO. The basis of allotment will be finalized on 31st January 2024 and the refunds will be initiated on 01st February 2024. In addition, the demat credits are also expected to happen on 01st February 2024 and the stock is scheduled to list on 02nd February 2024 on the NSE SME segment. This is the segment, in contrast to the mainboard, where IPOs of small and medium enterprises (SMEs) are incubated. The demat credits to the demat account to the extent of allotment will happen by the close of 01st February 2024 under ISIN Number (INE0OGG01015).